Thread by @Dr_AshokSeth

Treatment of #COVID19 gets a Boost; Lab produced Monoclonal Antibody cocktail drug (Casirivimab and Imdevimab), similar to human antibodies and prevent Corona virus infecting human cells, launched in India for use from today

Given as IV infusion, Useful in mild to moderate CoVID immediately after diagnosis in the first week, decreases chances of progression to hospitalisation, severe disease or death by 70%. Though expensive at Rs 60,000, could be life saving for those at highest risk of severe CoVID

elderly or those with multiple chronic diseases. Not useful once patient is admitted to hospital with moderate to severe disease needing oxygen and the protection is temporary. More information as we use it...
#COVID19 #coronavirus #StaySafe #GetVaccinated #MoHFW_INDIA #PMOIndia